Insiders / Venkatesan Jay
Venkatesan Jay
CIK 1413350personinsider
Companies
3
First seen
Jan 5, 2021
Last activity
Jun 22, 2026
Holdings
3 companies · 7 positionsView all →
| Company / security | Shares held | Latest |
|---|---|---|
| Nivalis Therapeutics, Inc. · ALPN | 2,876,372 | — |
| Common stock | 2,876,372 | Jul 15, 2022 |
| Options | 70,000 | Jul 15, 2022 |
| AgeX Therapeutics, Inc. · AGE | 232,294 | — |
| Common stock | 232,294 | Jun 17, 2026 |
| Options | 15,250 | Jun 17, 2026 |
| Angion Biomedica Corp. · ANG | 180,534 | — |
| Common stock | 180,534 | Nov 26, 2024 |
| Warrants | 50,000 | Nov 26, 2024 |
| Options | 7,900 | May 19, 2025 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Sep 17, 2021 | Sell Open-market sale | ALPN Nivalis Therapeutics, Inc. Common Stock | $3.76M | -400K -13.33% | 2,600,980 | medium |
| Feb 9, 2021 | Exercise In-the-money exercise | ANG Angion Biomedica Corp. Common Stock | $2.55M | +396K +32.97% | 1,598,440 8.37% of shares | low |
| Feb 9, 2021 | Sell Open-market sale | ANG Angion Biomedica Corp. Common Stock |